Tango Therapeutics Inc (TNGX) — Cash Flow-to-Debt Ratio
Tango Therapeutics Inc (TNGX) has a Cash Flow-to-Debt Ratio of -0.57x as of December 2025, meaning its operating cash flow of $-29.72 Million could theoretically repay -1% of its total liabilities ($52.51 Million) in one year. See free cash flow generation of Tango Therapeutics Inc to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Tango Therapeutics Inc Cash Flow-to-Debt Ratio (2019–2025)
Historical debt coverage capacity for Tango Therapeutics Inc across 7 annual periods. Also explore net asset momentum of Tango Therapeutics Inc to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Tango Therapeutics Inc (2019–2025)
Year-by-year debt coverage analysis for Tango Therapeutics Inc. For market capitalisation and broader financial context, see TNGX market cap.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.64x | $-138.89 Million | $52.51 Million | ▼ -135.3% |
| 2024 | -1.12x | $-131.50 Million | $116.97 Million | ▼ -42.4% |
| 2023 | -0.79x | $-117.98 Million | $149.46 Million | ▼ -35.3% |
| 2022 | -0.58x | $-109.08 Million | $186.99 Million | ▼ -52.3% |
| 2021 | -0.38x | $-59.53 Million | $155.41 Million | ▼ -192.2% |
| 2020 | 0.42x | $70.07 Million | $168.65 Million | ▲ +180.2% |
| 2019 | -0.52x | $-24.80 Million | $47.86 Million | — |